Healthcare & Life Sciences
Autobahn Therapeutics
United Statesautobahntx.com
Autobahn Therapeutics is a series b startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Autobahn Therapeutics
Autobahn Therapeutics is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Autobahn Therapeutics develops restorative treatments for people affected by neuropsychiatric and neuroimmunologic disorders, focusing on central nervous system (CNS) diseases such as major depressive disorder (MDD) and bipolar depression through innovative small molecule therapies.
Explore Autobahn Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.